Acrivon Therapeutics Revenue and Competitors

Boston, MA USA

Location

#3460

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Acrivon Therapeutics's estimated annual revenue is currently $12.1M per year.(i)
  • Acrivon Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Acrivon Therapeutics has 78 Employees.(i)
  • Acrivon Therapeutics grew their employee count by 37% last year.

Acrivon Therapeutics's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
VP Quality and ComplianceReveal Email/Phone
3
VP Finance and AccountingReveal Email/Phone
4
General CounselReveal Email/Phone
5
VP, Biology & Drug DiscoveryReveal Email/Phone
6
VP, Head Human ResourcesReveal Email/Phone
7
SVP, Head Clinical OperationsReveal Email/Phone
8
VP, Head Data ScienceReveal Email/Phone
9
SVP and Head, Investor Relations and Corporate AffairsReveal Email/Phone
10
SVP, Global Regulatory AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Acrivon Therapeutics?

Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mutations or synthetic lethal contexts. Leveraging our unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials. Acrivon Therapeutics and its clinical biomarker development group is headquartered in the greater Boston area, with biomarker discovery efforts concentrated in our wholly-owned subsidiary in Lund, Sweden.

keywords:N/A

N/A

Total Funding

78

Number of Employees

$12.1M

Revenue (est)

37%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.7M78-38%$156M
#2
$11.3M7856%N/A
#3
$12.1M785%N/A
#4
$22.6M787%N/A
#5
$8M783%N/A